rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2001-3-13
|
pubmed:abstractText |
Available data and our observations suggest that elevated levels of interleukin (IL)-6 and -10 and some complement parameters may be associated with a poor response to IFN alpha. We evaluated how baseline levels of C5b-9, IL-6, and IL-10 influence the outcome of IFN alpha treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0036-5521
|
pubmed:author |
pubmed-author:AbonyiMM,
pubmed-author:BíróLL,
pubmed-author:CsepregiAA,
pubmed-author:DávidKK,
pubmed-author:DalmiLL,
pubmed-author:HorányiMM,
pubmed-author:HorváthGG,
pubmed-author:IbrányiEE,
pubmed-author:KastGG,
pubmed-author:NagyII,
pubmed-author:NemesánszkyEE,
pubmed-author:PárAA,
pubmed-author:SzentgyörgyiLL,
pubmed-author:TelegdyLL,
pubmed-author:VargaLL
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1092-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11099064-Adult,
pubmed-meshheading:11099064-Biological Markers,
pubmed-meshheading:11099064-Complement Membrane Attack Complex,
pubmed-meshheading:11099064-Female,
pubmed-meshheading:11099064-Hepacivirus,
pubmed-meshheading:11099064-Hepatitis C, Chronic,
pubmed-meshheading:11099064-Humans,
pubmed-meshheading:11099064-Interferon-alpha,
pubmed-meshheading:11099064-Interleukin-10,
pubmed-meshheading:11099064-Interleukin-6,
pubmed-meshheading:11099064-Male,
pubmed-meshheading:11099064-RNA, Viral,
pubmed-meshheading:11099064-Recombinant Proteins,
pubmed-meshheading:11099064-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
C5b-9 and interleukin-6 in chronic hepatitis C. Surrogate markers predicting short-term response to interferon alpha-2b.
|
pubmed:affiliation |
National Institute of Hematology and Immunology, Budapest, Hungary.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|